Thursday, April 25, 2024

IBM, Moderna Seek to Improve COVID-19 Vaccine Supply Chain Visibility Via Open Technology

“IBM and Moderna have announced plans to collaborate to conduct a pilot of open technology-based approaches to improve visibility into the COVID-19 vaccine supply chain and monitor vaccine administration in real time.”

“IBM said Thursday initial work will focus on vaccine management platforms designed to prevent disruptions to the vaccine supply chain by enabling governments and health care providers to share data on individual batches of COVID-19 vaccines as they move from production facilities to administration sites.”

“‘As governments, pharmacy chains, healthcare providers and life sciences companies continue to scale and connect their tools, and as new players enter the supply chain, open technology can help drive more transparency and bolster trust, while helping to ensure accessibility and equity in the process,’ said Jason Kelley, managing partner and global strategic alliances leader for IBM.”

“The companies will also explore the use of Digital Health Pass in addressing the pandemic. The blockchain technology-based pass could help organizations verify vaccination records, test results and other health credentials of employees, travelers and customers while allowing individuals to control how they share their personal health data.”

“Moderna and IBM will also study the use of artificial intelligence, hybrid cloud and other technologies in support of COVID-19 vaccine management efforts…” Read the full article here.

Source: Moderna and IBM Plan to Collaborate on COVID-19 Vaccine Supply Chain and Distribution Data Sharing – March 4, 2021. IBM.

IBM was named to the list of NXT UP firms poised to make big waves in the Federal sector in 2020 and for years to come.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

FedHealthIT Xtra – Find Out More!

Recent News

Don’t Miss A Thing

Jackie Gilbert
Jackie Gilbert
Jackie Gilbert is a Content Analyst for FedHealthIT and Author of 'Anything but COVID-19' on the Daily Take Newsletter for G2Xchange Health and FedCiv.

Subscribe to our mailing list

* indicates required